GB PHARMA ApS: Financial statements 2022
CVR: 36054220
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
GB PHARMA ApS (CVR 36054220) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 42,725 and a net result of DKK 65,154 compared with DKK 2,571 the year before. The profit margin was 152.5%. Equity in the 2022 report amounted to DKK -1,898,574.
- Revenue
- DKK 42,725
- Gross Profit
- DKK 32,912
- Profit/Loss
- DKK 65,154
- Equity
- DKK -1,898,574
- Total Assets
- DKK 71,940
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 43 t. | 33 t. | 65 t. | -1.9 mio. | - |
| 2021 | 0 | -10 t. | 3 t. | -2 mio. | - |
| 2020 | 0 | -13 t. | -46 t. | -2 mio. | 1 |
| 2019 | 47 t. | 19 t. | 25 t. | -1.9 mio. | 0 |
| 2018 | 43 t. | 23 t. | 41 t. | -1.9 mio. | 0 |
Official annual report
Keep an eye on GB PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
GB PHARMA ApS has published its annual report for 2021. Revenue came to DKK 0, and the net result was DKK 2,571.
About GB PHARMA ApS
GB PHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2014. The company is registered under the industry Detailhandel med kosmetikvarer og toiletartikler. The management consists of Gunnar Kjems. The board consists of Gunnar Kjems (chair). The company is owned by Gunnar Kjems. The company has 0 employees (2016). In 2025, the company reported a gross profit of DKK -10,000 and a net result of DKK 31,613 compared with DKK -4,949 the year before. Equity in the 2025 report amounted to DKK -1,902,842.